Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 13, 2000

View Archived Issues

Tibotec Raises $36.5M Privately In Third Round For HIV Drugs

New Antigen-Delivery Method Could Boost Cancer Therapies

Genmab, Gemini Enter Broad Antibody Therapeutics Alliance

Other News To Note

EU Continues Effort To Balance Risks, Benefits Of Biotechnology

Existing Venture Investors Give Another #13M To Adprotech

Diversys Founded On Technology From Winter II Antibody Patents

Neurotech Shows ECT Works In Animals, Eyes Human Tests

German Company Arcensus Developing Pathogen Chips

Liponex Formed On Cholesterol Work From Ottawa Heart Institute

Compugen Expands Presence Through Office In California

Prodi Wants To Strengthen Ethics Advisory Group's Role

Immunobiology Raises Seed Funding For HSP Technology

bi12132000n.html

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026